How do I choose a psychedelic?

By elimination, not by preference. Four things narrow the field fast: what's legally available where you live, your medications and conditions, how long a session you can genuinely commit to, and who supports you afterwards. Work through those with a trained practitioner and the realistic list is short.

Most people approach this as a selection problem — read about the options, pick the appealing one. It works better as an elimination problem. Once you apply the real constraints in order, the field usually narrows to one or two realistic paths, and the remaining question becomes who you do it with.

Here is the order that actually saves time.

1. Start with legality, not appeal

In the United States in October 2026, supported above-ground access means one of four things: a licensed ketamine provider, Oregon's licensed psilocybin service centers, Colorado's licensed healing centers, or enrolment in a clinical trial. Everything else means travelling abroad or operating outside the law, each with consequences worth understanding before rather than after.

Local decriminalisation ordinances are frequently misread. They change enforcement priorities for possession. They do not create a legal service you can book, and they do not protect a practitioner who charges you for one.

2. Get the medical and medication question answered early

Antidepressants, mood stabilisers, lithium, MAOIs and cardiac medication all matter. A personal or family history of psychosis or bipolar disorder matters. So does a heart condition. None of this is something to resolve by reading; it needs the clinician who manages your care, and a practitioner who insists on knowing about it is showing you they are careful, not obstructive.

3. Be honest about the time a session takes

Sessions range from about forty minutes to twelve hours, and the difference is not a detail. A long session needs a cleared day, no obligations the following day, transport arranged in advance, and someone whose presence you can tolerate for the whole of it. If you cannot realistically hold that, that is useful information, not a failure of commitment.

4. Decide the format before the medicine

One-to-one, small group, retreat, virtual preparation and integration only — these are genuinely different products, and people often discover they had a preference they had never articulated. Of 239 completed preference records, 71 people — around 30% — told us they weren't sure which format they wanted. If that is you, it is worth a conversation rather than a guess: the format shapes the experience at least as much as the substance does.

5. Price it properly

A third of the people who complete our intake select a budget band under $500. Regulated psilocybin programmes in Colorado commonly run $3,500–$9,500 all in, and Oregon facilitation commonly $1,200–$3,500. Ketamine clinics typically charge $400–$800 per session in a series, and esketamine is the only option here that some insurers cover. Naming a real number at the start of a consultation prevents a lot of wasted time.

6. Plan the integration before the session

The weeks afterwards are where people report the actual change consolidating — or failing to. Ask what integration support is included before you agree to anything. If the answer is vague, that is the answer.

The questions worth bringing to a consultation

• Given my medications and history, what would you rule out, and why?
• What screening do you do before agreeing to work with someone, and what would make you say no?
• What training and how many hours of supported practice do you have — and can I verify it?
• What legal route are we operating in, and what does that mean for me?
• What happens if the session goes badly? Who is present, and what is the plan?
• What integration is included, and for how long afterwards?
• What does the total cost cover, and what is extra?

A practitioner who welcomes these questions is the signal you are looking for. One who deflects them has told you something useful.

Reading next: the six-medicine comparison, and how to vet a guide.

Where our numbers come from

Figures attributed to Guides Collective on this page come from our own intake questionnaire, completed by 281 adults between 23 December 2025 and 1 August 2026. They describe the people who came to us, not the general population, and they are self-reported. We publish them because nobody else in this category publishes anything comparable — not because they settle a clinical question.

Frequently asked questions

Sources

• Oregon Health Authority: Oregon Psilocybin Services.
• Colorado Department of Regulatory Agencies: Natural Medicine FAQs.
• FDA: esketamine (Spravato) approval history.
• Published pricing surveys of licensed Colorado healing centers.
• 988 Suicide & Crisis Lifeline.

About this page